Tabs
FDA Center:
CDER
Time Period:
January 1, 2006 and June 30, 2014
Study Type:
Modular Program
Assessment Type:
Exploratory Analyses
Population / Cohort:
All individuals with atrial fibrillation (AF)
Data Sources:
Mini-Sentinel Distributed Database (MSDD)